CytoSorbents Corporation is a medical technology company focused on critical care immunotherapy. The company develops and commercializes blood purification technologies, with its primary product CytoSorb, a broad-spectrum cytokine adsorber used in critical illness and cardiac surgery. CytoSorbents also develops related blood purification and drug removal technologies for clinical applications in intensive care and surgical settings.
Q2 FY2026 — expected 2026-09-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001104659-26-036451 | EDGAR | 62K words |
| 2025-03-31 | 2024-12-31 | 0001410578-25-000591 | EDGAR | — |
| 2024-03-15 | 2023-12-31 | 0001410578-24-000201 | EDGAR | — |
| 2023-03-09 | 2022-12-31 | 0001410578-23-000234 | EDGAR | — |
| 2022-03-10 | 2021-12-31 | 0001410578-22-000331 | EDGAR | — |
| 2021-03-09 | 2020-12-31 | 0001104659-21-033790 | EDGAR | — |
| 2020-03-05 | 2019-12-31 | 0001104659-20-029712 | EDGAR | — |
| 2019-03-07 | 2018-12-31 | 0001144204-19-012774 | EDGAR | — |
| 2018-03-08 | 2017-12-31 | 0001144204-18-013618 | EDGAR | — |
| 2017-03-03 | 2016-12-31 | 0001144204-17-012631 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001104659-25-111389 | EDGAR | 25K words |
| 2025-08-07 | 2025-06-30 | 0001410578-25-001612 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001410578-25-001268 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0001410578-24-001795 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001410578-24-001368 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001410578-24-000703 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001410578-23-002301 | EDGAR | — |
| 2023-08-01 | 2023-06-30 | 0001410578-23-001523 | EDGAR | — |
| 2023-05-02 | 2023-03-31 | 0001410578-23-000868 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0001410578-22-002932 | EDGAR | — |
| 2022-08-02 | 2022-06-30 | 0001410578-22-002018 | EDGAR | — |
| 2022-05-03 | 2022-03-31 | 0001410578-22-001133 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-02 | 0001104659-26-038859 | EDGAR | 1K words |
| 2026-03-25 | 0000929638-26-001150 | EDGAR | — |
| 2025-11-13 | 0000929638-25-004243 | EDGAR | — |
| 2025-10-03 | 0001104659-25-096675 | EDGAR | — |
| 2025-09-16 | 0000929638-25-003494 | EDGAR | — |
| 2025-08-20 | 0001104659-25-080908 | EDGAR | — |
| 2025-08-07 | 0000929638-25-002927 | EDGAR | — |
| 2025-08-01 | 0001104659-25-072805 | EDGAR | — |
| 2025-07-02 | 0001104659-25-065280 | EDGAR | — |
| 2025-06-24 | 0001104659-25-062097 | EDGAR | — |
403 total filings indexed. 371 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001175151 |
| Ticker | CTSO |
| Exchange | Nasdaq |
| SIC | 3841: Surgical & Medical Instruments & Apparatus |
| Incorporated | DE |
| Website | https://www.cytosorbents.com |
| Listed | 2005-05-17 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report